Induction of broadly neutralizing H1N1 influenza antibodies by vaccination

Science
Chih-Jen WeiGary J Nabel

Abstract

The rapid dissemination of the 2009 pandemic influenza virus underscores the need for universal influenza vaccines that elicit protective immunity to diverse viral strains. Here, we show that vaccination with plasmid DNA encoding H1N1 influenza hemagglutinin (HA) and boosting with seasonal vaccine or replication-defective adenovirus 5 vector encoding HA stimulated the production of broadly neutralizing influenza antibodies. This prime/boost combination increased the neutralization of diverse H1N1 strains dating from 1934 to 2007 as compared to either component alone and conferred protection against divergent H1N1 viruses in mice and ferrets. These antibodies were directed to the conserved stem region of HA and were also elicited in nonhuman primates. Cross-neutralization of H1N1 subtypes elicited by this approach provides a basis for the development of a universal influenza vaccine for humans.

References

Feb 25, 2006·Cell·Daniel C DouekGary J Nabel
Oct 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·Wing-Pui KongGary J Nabel
Apr 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Arun K KashyapRichard A Lerner
Jul 31, 2008·Expert Review of Vaccines·Jan Willem van der LaanJohn Oxford
Feb 24, 2009·Nature Structural & Molecular Biology·Jianhua SuiWayne A Marasco
Mar 3, 2009·Science·Damian C EkiertIan A Wilson
May 19, 2009·Nature Immunology·Peter D Kwong, Ian A Wilson
Apr 8, 2010·Science Translational Medicine·Giuseppe Del GiudiceRino Rappuoli
Apr 15, 2010·The Journal of Clinical Investigation·Davide CortiAntonio Lanzavecchia

❮ Previous
Next ❯

Citations

May 28, 2013·Archivum Immunologiae Et Therapiae Experimentalis·K Kai McKinstryTara M Strutt
May 21, 2013·Trends in Microbiology·Kanta Subbarao, Yumiko Matsuoka
Jun 8, 2011·Immunology and Cell Biology·Garry W LynchJohn S Sullivan
Apr 18, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jae-Min SongSang-Moo Kang
Jun 4, 2013·Nature Biotechnology·Alejandro B BalazsDavid Baltimore
Dec 20, 2013·Nature Immunology·Florian Krammer, Peter Palese
Nov 19, 2010·The New England Journal of Medicine·Linda C Lambert, Anthony S Fauci
Feb 8, 2013·The New England Journal of Medicine·Gary J Nabel
Oct 20, 2010·Proceedings of the National Academy of Sciences of the United States of America·Taia T WangPeter Palese
Feb 11, 2012·Proceedings of the National Academy of Sciences of the United States of America·Nimalan ArinaminpathyBryan T Grenfell
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Natalie PicaPeter Palese
Oct 3, 2012·Proceedings of the National Academy of Sciences of the United States of America·Peter S LeeIan A Wilson
Jan 12, 2011·The Journal of Experimental Medicine·Jens WrammertPatrick C Wilson
Apr 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jianhua SuiWayne A Marasco
Oct 31, 2012·The Journal of Infectious Diseases·Xiao-Song HeHarry B Greenberg
Mar 25, 2011·Journal of Molecular Cell Biology·Ethan C SettembreRino Rappuoli
Sep 7, 2011·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Ab OsterhausGuus Rimmelzwaan
Sep 7, 2011·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·David J Paton, Geraldine Taylor
Aug 28, 2010·Science·Robert W Doms
Jul 9, 2011·Science·Damian C EkiertJaap Goudsmit
Aug 13, 2011·Science·Taia T Wang, Peter Palese
Aug 11, 2012·Science·Cyrille DreyfusRobert H E Friesen
Aug 17, 2012·Science Translational Medicine·Chih-Jen WeiGary J Nabel
Sep 16, 2011·Clinical and Vaccine Immunology : CVI·J Patrick GorresSrinivas S Rao
Sep 8, 2012·Clinical and Vaccine Immunology : CVI·J E LedgerwoodUNKNOWN VRC 304 and VRC 305 Study Teams
Nov 23, 2011·Respiratory Research·Chad J RoySrinivas S Rao
Oct 13, 2010·BMC Biology·Stephen J TurnerAnne Kelso
Jul 28, 2013·Virology Journal·Masanori TerajimaFrancis A Ennis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.